Giving Standardized Estradiol Therapy in Transgender Women to Research Interactions with HIV Therapy: the GET IT RIgHT Study
A5403 is a phase IIb, 48-week, open-label, non-randomized, 3-group trial, of 90 adult (≥18 years) transgender women and other individuals identifying as female or transfeminine but with male sex assigned at birth (TW) living with HIV on suppressive antiretroviral therapy (ART) and not currently on FHT.
Age greater than or equal to 18 years. Documentation of HIV-1 status. Assigned male sex at birth and identifies as a TW, female or transfeminine person.
University of Colorado Hospital
Thomas Campbell, MD
Protocol Number: 23-1505
More information available at ClinicalTrials.gov: NCT06005610
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers